CD3G and neoplasm: The results showed that CCL17 and CD3G (CD4/CD8+ T cell marker molecule), CD4 (CD4+ T cell marker molecule), and CD79B (naive B-cell marker molecule) were expressed to some extent in tumor tissues of three LUAD patients without dysregulation.